Publications by authors named "M B Montello"

Background: Human anatomy has long been a foundational aspect of medical education. To innovate and refine educational methodologies, it is necessary to employ tools that streamline the organization of classroom objectives. One such tool is Bloom's taxonomy (BT), a two-dimensional framework that guides the selection of verbs in defining educational objectives for curriculum components and lesson plans.

View Article and Find Full Text PDF

Editing services within academic health centers are uncommon, and few studies have reported on their impact. In this article, we describe our medical writing center's editing service for faculty and trainees at a pediatric teaching hospital and associated outcomes of scholarly products (e.g.

View Article and Find Full Text PDF

Purpose: The biceps brachii muscle (BBM) is a large and thick muscle on the ventral portion of the upper arm. The scientific literature reports the existence of extra heads.

Objective: The present work investigated the frequency of occurrence of BBM accessory head(s) in four different Anatomy Laboratories at universities in Northeast Brazil.

View Article and Find Full Text PDF
Article Synopsis
  • - The National Cancer Institute revamped its early-phase drug development program in 2014, creating the Experimental Therapeutics Clinical Trials Network (ETCTN) to support collaboration across over 40 academic institutions for cancer research focused on tumors with specific molecular profiles.
  • - The ETCTN has achieved significant milestones, including the submission of 334 letters of intent, activation of 102 clinical trials, and enrollment of 3,570 patients, highlighting the effectiveness of team science and mentorship for emerging researchers.
  • - Future directions for the ETCTN emphasize continued collaboration, the importance of senior investigator involvement, and investment in infrastructure to enhance research and precision medicine in cancer trials, demonstrating the program's potential for impactful drug development.
View Article and Find Full Text PDF

The National Institutes of Health (NIH) issued a new policy that requires a single institutional review board (IRB) of record be used for all protocols funded by the NIH that are carried out at more than one site in the United States, effective January 2018. This policy affects several hundred clinical trials opened annually across the NIH. Limited data exist to compare the use of a single IRB to that of multiple local IRBs, so some institutions are resistant to or distrustful of single IRBs.

View Article and Find Full Text PDF